HWY-289, a novel semi-synthetic protoberberine derivative with multiple target sites in Candida albicans

Journal of Antimicrobial Chemotherapy

Volumn 47, Issue 5, 2001, Pages 513-519

  Park, Kang Sik ^a   Kang, Kap Chul ^a   Kim, Ki Young ^a   Jeong, Pan Young ^a   Kim, Jai Hyun ^a   Adams, David J ^b   Kim, Jung Ho ^c   Paik, Young Ki ^a  

^a Yonsei University   (South Korea)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c Hanwha Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CARBON 14; CHITIN SYNTHASE; CHOLESTEROL; ERGOSTEROL; FLUCONAZOLE; HWY 289; ISOENZYME; METHIONINE; MICONAZOLE; NIKKOMYCIN Z; PROTOBERBERINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CELL WALL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; ENZYME SPECIFICITY; IC 50; IN VITRO STUDY; MICROSOME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RAT;

EID: 0035002003     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/47.5.513     Document Type: Article

References (32)

1. Groll, A. H., De Lucca, A. J. & Walsh, T. J. (1998). Emerging targets for the development of novel antifungal therapeutics. Trends in Microbiology 6, 117-24.
2. Kaufman, C. A. & Carver, P. L. (1997). Antifungal agents in the 1990s. Current status and future developments. Drugs, 53, 539-49.
3. Lewis, R. E. & Klepser, M. E. (1999). The changing face of nosocomial candidemia: epidemiology, resistance, and drug therapy. American Journal of Health - System Pharmacy 56, 525-33.
4. Vanden Bossche, H., Dromer, F., Improvisi, I., Lozano-Chiu, M., Rex, J. H. & Sanglard, D. (1998). Antifungal drug resistance in pathogenic fungi. Medical Mycology 36, Suppl. 1, 119-28
5. Adams, D. J. (1997). Drug and pesticide resistance in fungi. In Molecular Genetics of Drug Resistance, (Hayes, J. D. & Wolf, C.R., Eds), pp. 31-80. Harwood Academic Publisher, Amsterdam.
6. Alexander, B. D. & Perfect, J. R. (1997). Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches. Drugs 54, 657-78.
7. Klepser, M. E., Ernst, E. J. & Pfaller, M. A. (1997). Update on antifungal resistance. Trends in Microbiology 5, 372-5.
8. Ator, M. A., Schmidt, S. J., Adams, J. L., Dolle, R. E., Kruse, L. I., Frey, C. L. et al. (1992). Synthesis, specificity, and antifungal activity of inhibitors of the Candida albicans delta 24-sterol methyltransferase. Journal of Medicinal Chemistry, 35, 100-6.
9. Jensen-Pergakes, K. L., Kennedy, M. A., Lees, N. D., Barbuch, R., Koegel, C. & Bard, M. (1998). Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutants. Antimicrobial Agents and Chemotherapy 42, 1160-7.
10. Park, K. S., Kang, K. C., Kim, J. H., Adams, D. J., Johng, T. N. & Paik, Y. K. (1999). Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans. Journal of Antimicrobial Chemotherapy 43, 667-74.
11. Mio, T., Yabe, T., Sudoh, M., Satoh, Y., Nakajima, T., Arisawa, M. & Yamada-Okabe, H. (1996). Role of three chitin synthase genes in the growth of Candida albicans. Journal of Bacteriology 178, 2416-9.
12. Ryder, N. S. & Dupont, M. C. (1984). Properties of a particulate squalene epoxidase from Candida albicans. Biochimica et Biophysica Acta 794, 466-71.
13. National Committee for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. NCCLS, Villanova, PA.
14. Barrett-Bee, K. J., Lane, A. C. & Turner, R. W. (1986). The mode of antifungal action of tolnaftate. Journal of Medical and Veterinary Mycology 24, 155-60.
15. Ryder, N. S. (1985). Effect of allylamine antimycotic agents on fungal sterol biosynthesis measured by sterol side-chain methylation. Journal of General Microbiology 131, 1595-602.
16. Kim, C. K., Jeon, K. I., Lim, D. M., Johng, T. N., Trzaskos, J. M., Gaylor, J. L. et al. (1995). Cholesterol biosynthesis from lanosterol: regulation and purification of rat hepatic sterol 14-reductase. Biochimica et Biophysica Acta 1259, 39-48.
17. Lee, E. Y., Lim, D. M., Yoo, S. E., Kim, D. K. & Paik, Y.-K. (1999). Biochemical basis for a cholesterol-lowering activity of 2-[2″-(1″,3″-dioxolane)]-2-methyl-4-(2′-oxo-1′- pyrrolidinyl)-6-nitro-2H-1-benzopyran (SKP-450), a novel antihypertensive agent. Biochemical Pharmacology 57, 579-82.
18. Ator, M. A., Schmidt, S. J., Adams, J. L. & Dolle, R. E. (1989). Mechanism and inhibition of delta 24-sterol methyltransferase from Candida albicans and Candida tropicalis. Biochemistry 28, 9633-40.
19. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72, 248-54.
20. Causier, B. E., Milling, R. J., Foster, S. G. & Adams, D. J. (1994). Characterization of chitin synthase from Botrytis cinerea. Microbiology 140, 2199-205.
21. Becker, J. M., Marcus, S., Tallock, J., Miller, D., Krainer, E., Khare, R. K. et al. (1988). Use of the chitin-synthesis inhibitor nikkomycin to treat disseminated candidiasis in mice. Journal of Infectious Diseases 157, 212-4.
22. Gaughran, J. P., Lai, M. H., Kirsch, D. R. & Silverman, S. J. (1994). Nikkomycin Z is a specific inhibitor of Saccharomyces cerevisiae chitin synthase isozyme Chs3 in vitro and in vivo. Journal of Bacteriology 176, 5857-60.
23. Choi, W. J. & Cabib, E. (1994). The use of divalent cations and pH for the determination of specific yeast chitin synthetases. Analytical Biochemistry 219, 368-72.
24. Trzaskos, J. M., Fischer, R. T. & Favata, M. F. (1986). Mechanistic studies of lanosterol C-32 demethylation. Conditions which promote oxysterol intermediate accumulation during the demethylation process. Journal of Biological Chemistry 261, 16937-42.
25. Cho, S. Y., Kim, J. H. & Paik, Y.-K. (1998). Cholesterol biosynthesis from lanosterol: differential inhibition of sterol delta 8-isomerase and other lanosterol-converting enzymes by tamoxifen. Molecules and Cells 8, 233-9.
26. Bae, S. H. & Paik, Y.-K. (1997). Cholesterol biosynthesis from lanosterol: development of a novel assay method and characterization of rat liver microsomal lanosterol delta 24-reductase. Biochemical Journal, 326, 609-16.
27. Lee, J. N. and Paik, Y.-K. (1997). Cholesterol biosynthesis from lanosterol: development of a novel assay method, characterization, and solubilization of rat hepatic microsomal sterol delta7-reductase. Journal of Biochemistry and Molecular Biology 30, 370-7.
28. Bowen, A. R., Chen-Wu, J. L., Momany, M., Young, R., Szaniszlo, P. J. & Robbins, P. W. (1992). Classification of fungal chitin synthases. Proceedings of the National Academy of Sciences, USA 89, 519-23.
29. Bulawa, C. E., Miller, D. W., Henry, L. K. & Becker, J. M. (1995). Attenuated virulence of chitin-deficient mutants of Candida albicans. Proceedings of the National Academy of Sciences, USA 92, 10570-4.
30. Munro, C. A., Schofield, D. A., Gooday, G. W. & Gow, N. A. (1998). Regulation of chitin synthesis during dimorphic growth of Candida albicans. Microbiology 144, 391-401.
31. Chen-Wu, J. L., Zwicker, J., Bowen, A. R. & Robbins, P. W. (1992). Expression of chitin synthase genes during yeast and hyphal growth phases of Candida albicans. Molecular Microbiology 6, 497-502.
32. Sudoh, M., Nagahashi, S., Doi, M., Ohta, A., Takagi, M. & Arisawa, M. (1993). Cloning of the chitin synthase 3 gene from Candida albicans and its expression during yeast-hyphal transition. Molecular and General Genetics 241, 351-8.